Techne ($TECH), a manufacturer of biological research products, has agreed to buy diagnostics outfit Bionostics for $104 million, a deal it expects to close early next year. Bionostics sells control solutions for the development of in vitro diagnostics, and Techne plans to roll the company's offerings into its R&D Systems business. More